Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
rasburicase
rasburicase
- Restricted Elitek --> Restricted to oncology for use in hyperuricemia in patients who meet criteria for use.
- Restricted Miscellaneous Formulary
Last updated: Apr. 5, 2024
- Black Box Warning: Anaphylaxis; hemolysis; methemoglobinemia; uric acid measure interference
Elitek ADULT Criteria for Use (In emergent, after-hours cases, rasburicase may be ordered by a non-oncology provider given the criteria for use is met).
Adults: Use restricted to oncology prescribers for treatment of hyperuricemia in patients who meet approved criteria set. Use criteria set for patient selection and protocol order set for adult patients.
Adult Dose Capping: Initial dose is capped at 3 mg for patients weight <90 kg and baseline uric acid level <18 mg/dL
Pediatrics: Restricted to use by oncology prescribers.
PEDIATRIC Rasburicase Criteria for Use
Pediatric Dose Rounding:
Reviewed: January 23, 2007
Updated: June 2021 (Pediatric Criteria, Dose Rounding), March 2024 (After Hours)